Condition: Relapsing Multiple Sclerosis · Sponsor: Hoffmann-La Roche
This open label, single arm study will evaluate the PK and PD effects of fenebrutinib in children and adolescents with RMS aged between 10 and \< 18 years. This study consists of a Dose Exploration Period and an Optional Extension Period. Eligible participants may choose to continue treatment with fenebrutinib in the optional extension period after completing the dose exploration period.
This description comes directly from the study's public registry record.
Reference Study ID Number: CN45847 https://forpatients.roche.com/ · 888-662-6728 (U.S.) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. No email attachments. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| INECO Neurociencias Orono | Rosario, Santa Fe Province, Argentina | Recruiting |
| Sanatorio del Sur S.A. | San Miguel de Tucumán, Argentina | Recruiting |
| L2IP ?Instituto de Pesquisas Clínicas Ltda. | Brasília, Federal District, Brazil | Recruiting |
| Instituto de Neurologia de Curitiba - Hospital Ecoville | Curitiba, Paraná, Brazil | Recruiting |
| Nucleo de Pesquisa Clinica do Rio Grande do Sul NPCR | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Centro de Pesquisas Clinicas - CPCLIN | São Paulo, São Paulo, Brazil | Recruiting |
| Clinstile S.A de C.V. | Mexico City, Mexico CITY (federal District), Mexico | Recruiting |
| Neurociencias Estudios Clinicos S.C. | Culiacán, Sinaloa, Mexico | Recruiting |
| Uniwersyteckie Centrum Kliniczne | Gdansk, Poland | Recruiting |
| Uniwersytecki Szpital Kliniczny w Poznaniu | Poznan, Poland | Recruiting |
| Instytut "Pomnik - Centrum Zdrowia Dziecka" | Warsaw, Poland | Recruiting |
| Centro Clnico Acadmico - Braga, Associao (2CA-Braga) | Braga, Portugal | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07161258